| Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations (NCT04216472) | M.D. Anderson Cancer Center | 2020-07-10 |
| Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients (NCT04443413) | Mayo Clinic | 2020-06-16 |
| Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand (NCT04876378) | University of California, San Francisco | 2020-05-18 |
| Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer (NCT04294225) | Mayo Clinic | 2020-04-28 |
| CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy (NCT04266249) | ECOG-ACRIN Cancer Research Group | 2020-03-13 |
| Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial (NCT04716920) | Thomas Jefferson University | 2020-03-11 |
| Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors (NCT04200482) | Fred Hutchinson Cancer Center | 2020-02-21 |
| Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM) (NCT04866992) | University of Texas Southwestern Medical Center | 2020-02-01 |
| Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer (NCT03979508) | Mayo Clinic | 2020-01-10 |
| Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer (NCT04081389) | Roswell Park Cancer Institute | 2019-12-06 |
| Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors (NCT03953157) | Jonsson Comprehensive Cancer Center | 2019-10-07 |
| Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer (NCT04001829) | ECOG-ACRIN Cancer Research Group | 2019-08-09 |
| Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted (NCT04185311) | Jonsson Comprehensive Cancer Center | 2019-07-10 |
| Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer (NCT03939481) | SWOG Cancer Research Network | 2019-05-14 |
| Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer (NCT04678414) | M.D. Anderson Cancer Center | 2019-04-01 |
| Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors (NCT03751449) | Roswell Park Cancer Institute | 2019-03-25 |
| Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors (NCT04454086) | Ohio State University Comprehensive Cancer Center | 2019-03-06 |
| EXERCISING TOGETHER for Couples Coping With Cancer (NCT03630354) | OHSU Knight Cancer Institute | 2019-01-18 |
| Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer (NCT03786354) | Ohio State University Comprehensive Cancer Center | 2019-01-09 |
| A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer (NCT04086875) | Thomas Jefferson University | 2018-11-07 |
| Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy (NCT03666819) | Mayo Clinic | 2018-09-10 |
| Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer (NCT03774472) | M.D. Anderson Cancer Center | 2018-08-20 |
| M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer (NCT03620201) | M.D. Anderson Cancer Center | 2018-08-03 |
| Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer (NCT03505671) | Wake Forest University Health Sciences | 2018-08-03 |
| Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer (NCT03505736) | Wake Forest University Health Sciences | 2018-06-21 |
| Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors (NCT03523195) | Fred Hutchinson Cancer Center | 2018-04-18 |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer (NCT02876640) | National Cancer Institute (NCI) | 2018-03-16 |
| Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer (NCT03132467) | M.D. Anderson Cancer Center | 2017-06-13 |
| Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer (NCT03106077) | M.D. Anderson Cancer Center | 2017-06-05 |
| Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer (NCT02918474) | M.D. Anderson Cancer Center | 2017-04-28 |
| Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy (NCT05049746) | M.D. Anderson Cancer Center | 2016-02-23 |
| Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer (NCT01334021) | M.D. Anderson Cancer Center | 2011-05-31 |
| Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors (NCT03708055) | University of Arizona | 2008-07-24 |
| Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer (NCT00507923) | M.D. Anderson Cancer Center | 2006-11-07 |